Nicola Fenderico

10PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsBiomedical instrumentation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

|Oct 28, 2025
Collaborative Funding Model to Improve Quality of Care for Metastatic Breast Cancer in Europe.

Matti S Aapro, Jacqueline Waldrop, Oriana Ciani

|Nov 09, 2022
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells.

Adrià Cañellas-Socias, Carme Cortina, Xavier Hernando-Momblona

|Nov 05, 2020
Publisher Correction: Mutations and mechanisms of WNT pathway tumour suppressors in cancer.

Jeroen M Bugter, Nicola Fenderico, Madelon M Maurice

|Oct 24, 2020
Mutations and mechanisms of WNT pathway tumour suppressors in cancer.

Jeroen M Bugter, Nicola Fenderico, Madelon M Maurice

Pageof 2